IHI Performance — iShares U.S. Medical Devices ETF
Data updated: 2026-08-24
IHI returned −20.32% year to date and −20.77% over one year to Jun 2026. Annualised returns are −3.88% over 3 years and −3.42% over 5 years. The fund trailed its Health Care Equity category average: $100 invested three years ago grew to $89, against $138 for the category, and to $79 over one year, against $137. Volatility over the past three years was 17.59% a year. In the 12 months to Jun 2026 the fund lost a net $767.8M, and assets reached $3.02B.
IHI Growth of $100
What $100 invested in iShares U.S. Medical Devices ETF grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Health Care Equity category average over the same months.
| Period | IHI | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $79 | $137 |
| 3 years (Jul 2023 – Jun 2026) | $89 | $138 |
| 5 years (Jul 2021 – Jun 2026) | $84 | $121 |
| Since data start (Jul 2019 – Jun 2026) | $127 | $182 |
IHI Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | −20.32% |
| 1 year | −20.77% |
| 3 years (annualised) | −3.88% |
| 5 years (annualised) | −3.42% |
IHI Annual Returns
Calendar-year total returns of iShares U.S. Medical Devices ETF, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | −20.32% |
| 2025 | +6.87% |
| 2024 | +8.62% |
| 2023 | +3.22% |
| 2022 | −19.71% |
| 2021 | +21.04% |
| 2020 | +24.18% |
| 2019 (Jul–Dec) | +10.03% |
IHI Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | −3.4% | +0.3% | −11.4% | −4.3% | −4.1% | +1.1% | — | — | — | — | — | — |
| 2025 | +9.4% | −0.1% | −5.6% | −0.7% | +3.5% | +1.3% | −4.7% | +4.1% | −3.2% | +0.1% | +7.0% | −3.3% |
| 2024 | +3.4% | +1.8% | +3.1% | −6.1% | +0.9% | +1.0% | −2.0% | +7.2% | +0.8% | −1.8% | +4.9% | −4.2% |
| 2023 | +2.6% | −3.6% | +3.9% | +5.1% | −6.8% | +6.8% | −0.6% | −6.4% | −7.4% | −6.7% | +10.8% | +7.8% |
| 2022 | −10.2% | +0.2% | +2.9% | −9.6% | −1.1% | −7.3% | +6.6% | −5.9% | −6.6% | +6.6% | +5.7% | −0.8% |
| 2021 | +1.9% | −1.2% | +0.3% | +7.2% | −2.2% | +4.3% | +5.9% | +2.9% | −4.1% | +4.2% | −5.4% | +6.5% |
| 2020 | +0.2% | −8.5% | −7.0% | +14.2% | +4.2% | −1.2% | +10.8% | +3.6% | −1.1% | −0.8% | +5.1% | +4.7% |
| 2019 | — | — | — | — | — | — | +2.2% | +1.4% | −0.8% | +0.6% | +4.3% | +1.9% |
IHI Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 17.59%
- 3-year Sharpe ratio: -0.48 (vs 4.5% risk-free rate)
- Best month: +10.78% (Nov 2023)
- Worst month: −11.37% (Mar 2026)
IHI Fund Flows
Monthly money in and out of iShares U.S. Medical Devices ETF, from SEC Form N-PORT.
- 12-month net flow: −$767.8M
- 12-month gross sales (incl. reinvestments): $1.8B
- Sales ÷ redemptions: 0.70×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $254.8M | $246.4M | $8.4M |
| May 2026 | $293.3M | $366.7M | −$73.4M |
| Apr 2026 | $347.9M | $186.6M | $161.3M |
| Mar 2026 | $172.4M | $214.5M | −$42.2M |
| Feb 2026 | $157.9M | $256.1M | −$98.2M |
| Jan 2026 | $213.6M | $407.7M | −$194.1M |
| Dec 2025 | $103.1M | $257.2M | −$154.1M |
| Nov 2025 | $47.2M | $94.8M | −$47.6M |
| Oct 2025 | $63.0M | $136.0M | −$73.0M |
| Sep 2025 | $103.3M | $112.6M | −$9.4M |
| Aug 2025 | $30.7M | $101.5M | −$70.9M |
| Jul 2025 | $43.1M | $217.9M | −$174.8M |
IHI Assets Under Management
Net assets of iShares U.S. Medical Devices ETF by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $3.02B |
| 2026-03-31 | $3.17B |
| 2025-12-31 | $4.05B |
| 2025-09-30 | $4.18B |
| 2025-06-30 | $4.62B |
| 2025-03-31 | $4.64B |
| 2024-12-31 | $4.40B |
| 2024-09-30 | $4.98B |
| 2024-06-30 | $5.13B |
| 2024-03-31 | $5.76B |
| 2023-12-31 | $5.38B |
| 2023-09-30 | $5.07B |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.